AXIC A Stock Overview
A biotechnology company, engages in the development of natural analogue ingredients in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
aXichem AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.17 |
| 52 Week High | SEK 11.50 |
| 52 Week Low | SEK 0.90 |
| Beta | 0.039 |
| 11 Month Change | -10.69% |
| 3 Month Change | -2.90% |
| 1 Year Change | -83.29% |
| 33 Year Change | -95.26% |
| 5 Year Change | -98.57% |
| Change since IPO | -93.11% |
Recent News & Updates
Shareholder Returns
| AXIC A | SE Chemicals | SE Market | |
|---|---|---|---|
| 7D | -7.1% | 0.6% | -2.1% |
| 1Y | -83.3% | -6.5% | 10.8% |
Return vs Industry: AXIC A underperformed the Swedish Chemicals industry which returned -7.9% over the past year.
Return vs Market: AXIC A underperformed the Swedish Market which returned 12.5% over the past year.
Price Volatility
| AXIC A volatility | |
|---|---|
| AXIC A Average Weekly Movement | 15.4% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: AXIC A's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: AXIC A's weekly volatility has decreased from 21% to 15% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 7 | Torsten Helsing | www.axichem.com |
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
aXichem AB Fundamentals Summary
| AXIC A fundamental statistics | |
|---|---|
| Market cap | SEK 69.16m |
| Earnings (TTM) | -SEK 17.19m |
| Revenue (TTM) | SEK 7.24m |
9.6x
P/S Ratio-4.0x
P/E RatioIs AXIC A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXIC A income statement (TTM) | |
|---|---|
| Revenue | SEK 7.24m |
| Cost of Revenue | SEK 1.07m |
| Gross Profit | SEK 6.17m |
| Other Expenses | SEK 23.36m |
| Earnings | -SEK 17.19m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 85.26% |
| Net Profit Margin | -237.53% |
| Debt/Equity Ratio | 7.7% |
How did AXIC A perform over the long term?
See historical performance and comparison